| 利用者成果(英) |
|
21605
Yamagishi M, Kuze Y, Kobayashi S, Nakashima M, Morishima S, Kawamata T, Makiyama J, Suzuki K, Seki M, Abe K, Imamura K, Watanabe E, Tsuchiya K, Yasumatsu I, Takayama G, Hizukuri Y, Ito K, Taira Y, Nannya Y, Tojo A, Watanabe T, Tsutsumi S, Suzuki Y, Uchimaru K.
Mechanisms of action and resistance in histone methylation-targeted therapy.
Nature
2024
627(8002):221-228
PubMed ID: 38383791
DOI: 10.1038/s41586-024-07103-x
|
|
19696
Watanabe M, Hatsuse H, Nagao K, Tanaka Y, Watanabe T, Horie R.
CD30 stimulation induces multinucleation and chromosomal instability in HTLV-1-infected cell lines
Int J Hematol
2023
118(1):75-87
PubMed ID: 37014603
DOI: 10.1007/s12185-023-03583-1
|
|
19979
Kurahashi Y, Watanabe T, Yamamoto Y, Ureshino H, Kamachi K, Yoshida-Sakai N, Fukuda-Kurahashi Y, Yamashita S, Hattori N, Nakamura H, Kawaguchi A, Ushijima T, Sueoka E, Kimura S.
Dual targeting of aberrant DNA and histone methylation synergistically suppresses tumor cell growth in ATL
. 2023 Apr 25;7(8):1545-1559
2023
7(8):1545-1559
PubMed ID: 36516085
DOI: 10.1182/bloodadvances.2022008362
|
|
20599
Wang Y, Zheng N, Sun T, Zhao H, Chen Y, Liu C.
Role of TGM2 in T‑cell lymphoblastic lymphoma via regulation of IL‑6/JAK/STAT3 signalling.
Mol Med Rep
2022
25(3)
PubMed ID: 35014680
DOI: 10.3892/mmr.2022.12592
|
|
16945
Yano H, Fujiwara Y, Horlad H, Pan C, Kai K, Niino D, Ohsawa K, Higashi M, Nosaka K, Okuno Y, Tamaru JI, Mukasa A, Matsuoka M, Komohara Y.
Blocking cholesterol efflux mechanism is a potential target for antilymphoma therapy
Cancer Sci
2022
113(6):2129-2143
PubMed ID: 35343027
DOI: 10.1111/cas.15349
|
|
10693
Tatsuro Watanabe, Satoshi Yamashita, Hiroshi Ureshino, Kazuharu Kamachi, Yuki Kurahashi, Yuki Fukuda-Kurahashi, Nao Yoshida, Naoko Hattori, Hideaki Nakamura, Akemi Sato, Atsushi Kawaguchi, Naoko Sueoka-Aragane, Kensuke Kojima, Seiji Okada, Toshikazu Ushijima, Shinya Kimura, Eisaburo Sueoka
Targeting Aberrant DNA Hypermethylation as a Driver of ATL Leukemogenesis Using the New Oral Demethylating Agent OR-2100
Blood
2020
136(7):871-884
PubMed ID: 32391874
DOI: 10.1182/blood.2019003084
|
|
10951
Yanlan Wang, Yue Liu, Changhua Zhou, Chunnian Wang, Ning Zhang, Donglin Cao, Qing Li, Zhong Wang
An AKR1C3-specific prodrug with potent anti-tumor activities against T-ALL
Leuk Lymphoma
2020
61(7):1660-1668
PubMed ID: 32091283
DOI: 10.1080/10428194.2020.1728746
|
|
13930
Kawamura K, Tanaka Y, Nakasone H, Ishihara Y, Kako S, Kobayashi S, Tanaka Y, Ohmori T, Uchimaru K, Okamoto S, Mineno J, Shiku H, Nishimura S, Kanda Y.
Development of a Unique T Cell Receptor Gene-Transferred Tax-Redirected T Cell Immunotherapy for Adult T Cell Leukemia
Biol Blood Marrow Transplant
2020
26(8):1377-1385
PubMed ID: 32311478
DOI: 10.1016/j.bbmt.2020.04.006
|
|
11579
Watanabe M, Sugawara A, Noguchi Y, Hirose T, Ōmura S, Sunazuka T, Horie R.
Jietacins, azoxy natural products, as novel NF-κB inhibitors: Discovery, synthesis, biological activity, and mode of action.
Eur J Med Chem
2019
178:636-647
PubMed ID: 31226655
DOI: 10.1016/j.ejmech.2019.05.079
|
|
6834
Yamagishi M et al
Targeting Excessive EZH1 and EZH2 Activities for Abnormal Histone Methylation and Transcription Network in Malignant Lymphomas.
Cell Rep
2019
29(8):2321-2337
PubMed ID: 31747604
DOI: 10.1016/j.celrep.2019.10.083
|
|
4150
Ito T, Kasai Y, Kumagai Y, Suzuki D, Ochiai-Noguchi M, Irikura D, Miyake S, Murakami Y.
Quantitative Analysis of Interaction Between CADM1 and Its Binding Cell-Surface Proteins Using Surface Plasmon Resonance Imaging.
Front Cell Dev Biol
2018
PubMed ID: 30131958
DOI: 10.3389/fcell.2018.00086
|
|
10269
Komohara Y, Ma C, Yano H, Pan C, Horlad H, Saito Y, Ohnishi K, Fujiwara Y, Okuno Y, Nosaka K, Shimosaki S, Morishita K, Matsuoka M, Wakayama T, Takeya M.
Cell adhesion molecule-1 (CADM1) expressed on adult T-cell leukemia/lymphoma cells is not involved in the interaction with macrophages
J Clin Exp Hematop
2017
57:15-20
PubMed ID: 28420814
DOI: 10.3960/jslrt.17003
|
|
9736
Horlad H, Ohnishi K, Ma C, Fujiwara Y, Niino D, Ohshima K, Jinushi M, Matsuoka M, Takeya M, Komohara Y.
TIM-3 expression in lymphoma cells predicts chemoresistance in patients with adult T-cell leukemia/lymphoma.
Oncol Lett
2016
12:1519-1524
PubMed ID: 27446463
DOI: 10.3892/ol.2016.4774
|
|
18335
Matsumoto K, Murao K, Imachi H, Nishiuchi T, Cao W, Yu X, Li J, Ahmed RA, Iwama H, Kobayashi R, Tokumitsu H, Ishida T.
The role of calcium/calmodulin-dependent protein kinase cascade on MIP-1alpha gene expression of ATL cells
Exp Hematol
2008
36(4):390-400
PubMed ID: 18249060
DOI: 10.1016/j.exphem.2007.11.013
|
|
17374
Nagafuchi S, Katsuta H, Koyanagi-Katsuta R, Yamasaki S, Inoue Y, Shimoda K, Ikeda Y, Shindo M, Yoshida E, Matsuo T, Ohno Y, Kogawa K, Anzai K, Kurisaki H, Kudoh J, Harada M, Shimizu N.
Autoimmune regulator (AIRE) gene is expressed in human activated CD4+ T-cells and regulated by mitogen-activated protein kinase pathway
Microbiol Immunol
2006
50(12):979-87
PubMed ID: 17179667
DOI: 10.1111/j.1348-0421.2006.tb03876.x
|
戻る
細胞材料の再培養方法 (
HPS以外・
HPS )
ページトップへ
細胞材料開発室サイト
